Bildkälla: Stockfoto

Alligator Bioscience: Redeye resumes coverage following rights issue - Redeye

Redeye resumes its coverage of Alligator following the rights issue adding SEK 181m (before transaction costs) to the company's balance sheet.

Redeye resumes its coverage of Alligator following the rights issue adding SEK 181m (before transaction costs) to the company's balance sheet.
Börsvärldens nyhetsbrev
ANNONSER